Testicular function after cytotoxic chemotherapy: Evidence of leydig cell insufficiency

Journal of Clinical Oncology

Volumn 17, Issue 5, 1999, Pages 1493-1498

  Howell, S J ^a   Radford, J A ^a   Ryder, W D J ^a   Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLLITROPIN; LUTEINIZING HORMONE; MELPHALAN; PREDNISONE; PROCARBAZINE; SEX HORMONE BINDING GLOBULIN; VINBLASTINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MEGADOSE; FOLLITROPIN BLOOD LEVEL; GONAD DYSFUNCTION; HODGKIN DISEASE; HUMAN; LEYDIG CELL; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TESTIS FUNCTION;

EID: 0032921613     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.5.1493     Document Type: Article

References (17)

1. Spitz S: The histological effects of nitrogen mustard on human tumours and tissues. Cancer 1:383-398, 1948
2. Whitehead E, Shalet SM, Blackledge G, et al: The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male. Cancer 49:418-422, 1982
3. Chapman RM, Sutcliffe SB, Rees LH, et al: Cyclical combination chemotherapy and gonadal function: Retrospective study in males. Lancet 1:285-289, 1979
4. Charak BS, Gupta R, Mandrekar P, et al: Testicular dysfunction after cyclophosphamide-vincristine-procarbazine-prednisolone chemotherapy for advanced Hodgkin's disease: A long-term follow-up study. Cancer 65:1903-1906, 1990
5. Viviani S, Ragni G, Santoro A, et al: Testicular dysfunction in Hodgkin's disease before and after treatment. Eur J Cancer 27:1389-1392, 1991
6. Chatterjee R, Mills W, Katz M, et al: Germ cell failure and Leydig cell insufficiency in post-pubertal males after autologous bone marrow transplantation with BEAM for lymphoma. Bone Marrow Transplant 13:519-522, 1994
7. Hastie TJ, Tibshirani RJ: Generalised additive models. London, United Kingdom, Chapman and Hall, 1990
8. Bramswig JH, Heimes U, Heiermann E, et al: The effects of different cumulative doses of chemotherapy on testicular function: Results in 75 patients treated for Hodgkin's disease during childhood or adolescence. Cancer 65:1298-1302, 1990
9. Mackie EJ, Radford M, Shalet SM: Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 27:74-78, 1996
10. Wang J, Galil KA, Setchell BP: Changes in testicular blood flow and testosterone production during aspermatogenesis after irradiation. J Endocrinol 98:35-46, 1983
11. Setchell BP, Galil KA: Limitations imposed by testicular blood flow on the function of Leydig cells in rats in vivo. Aust J Biol Sci 36:285-293, 1983
12. Carreau S: Paracrine control of human Leydig cell and Sertoli cell functions. Folia Histochem Cytobiol 34:111-119, 1996
13. Huhtaniemi I, Toppari J: Endocrine, paracrine and autocrine regulation of testicular steroidogenesis. Adv Exp Med Biol 377:33-54, 1995
14. Viviani S, Santoro A, Ragni G, et al: Gonadal toxicity after combination chemotherapy for Hodgkin's disease: Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 21:601-605, 1985
15. Lampe H, Horwich A, Norman A, et al: Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol 15:239-245, 1997
16. Shamberger RC, Sherins RJ, Rosenberg SA: The effects of postoperative adjuvant chemotherapy and radiotherapy on testicular function in men undergoing treatment for soft tissue sarcoma. Cancer 47:2368-2374, 1981
17. Holmes SJ, Whitehouse RW, Clark ST, et al: Reduced bone mineral density in men following chemotherapy for Hodgkin's disease. Br J Cancer 70:371-375, 1994